Tengfei Creation Center,55 Jiangjun Avenue, Jiangning District,Nanjing admin@sinochem-nanjing.com 3389378665@qq.com
Follow us:

Trazodone

    • Product Name Trazodone
    • Alias Desyrel
    • Einecs 228-122-4
    • Mininmum Order 1 g
    • Factory Site Tengfei Creation Center,55 Jiangjun Avenue, Jiangning District,Nanjing
    • Price Inquiry admin@sinochem-nanjing.com
    • Manufacturer Sinochem Nanjing Corporation
    • CONTACT NOW
    VTB
    Specifications

    HS Code

    271189

    Generic Name Trazodone
    Brand Names Desyrel, Oleptro
    Drug Class Serotonin antagonist and reuptake inhibitor (SARI)
    Indications Depression, anxiety disorders, insomnia
    Dosage Forms Tablet, extended-release tablet
    Route Of Administration Oral
    Mechanism Of Action Inhibits serotonin reuptake and blocks 5-HT2A receptors
    Common Side Effects Drowsiness, dry mouth, dizziness, headache
    Controlled Substance No
    Prescription Status Prescription-only
    Half Life 5-13 hours
    Metabolism Hepatic (CYP3A4 enzyme)
    Pregnancy Category Category C
    Protein Binding 89-95%
    Warnings Risk of suicidal thoughts in young adults

    As an accredited Trazodone factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.

    Packing & Storage
    Packing Trazodone comes in a white plastic bottle containing 100 tablets, labeled with dosage strength, manufacturer details, and usage instructions.
    Shipping Trazodone should be shipped in tightly sealed, properly labeled containers, protected from light and moisture. The packaging must comply with local, national, and international regulations for pharmaceutical products. Temperature conditions should generally be controlled (15–30°C). Handle with care to avoid breakage or contamination during transit, ensuring product integrity upon delivery.
    Storage Trazodone should be stored at room temperature, typically between 20°C and 25°C (68°F and 77°F). Keep the medication in a tightly closed container, away from moisture, heat, and direct light. Store it out of reach of children and pets, and do not store it in the bathroom. Proper storage helps maintain the medication’s effectiveness and safety.
    Application of Trazodone

    Applications of Trazodone in Industrial Manufacturing

    As a manufacturer with pharmaceutical-grade synthesis and regulatory expertise, we support global partners in leveraging trazodone as a specialty raw material within several advanced industrial sectors. The following sections detail authentic downstream settings where trazodone is incorporated as an active ingredient, with a focus on compliance, process integration, dosing, and finished product applications aligned with strict 2026 quality frameworks.

    1. Pharmaceutical Finished Dosage Forms – Antidepressants

    Pharmaceutical formulation companies source trazodone for primary use in the manufacture of oral dosage forms designed for major depressive disorder and related psychiatric indications. Active ingredient specifications follow pharmacopeial monographs and are strictly monitored through analytical batch release protocols. Manufacturers blend trazodone into tablets or capsules during high-shear granulation, followed by controlled drying and compression or encapsulation. Finished goods target international regulated markets and must pass stringent release testing and stability profiling per their product registration dossiers.

    Industry compliance standards

    • United States Pharmacopeia (USP-NF)
    • European Pharmacopoeia (Ph. Eur.)
    • Current Good Manufacturing Practice (cGMP, 21 CFR Part 210/211, EU GMP Vol 4)
    • ICH Q6A Specifications and Q7 API GMP Guidelines

    Typical usage ratio

    • Active pharmaceutical ingredient load: 25mg–150mg per tablet or capsule, adjusted according to therapeutic target and country registration
    • Percentage in formulation: 6–25% w/w in matrix, based on excipient ratio and strength

    Downstream process integration

    • API addition during initial dry blending or wet granulation phase
    • Inline content uniformity and particle size monitoring
    • Integration into continuous direct compression lines or batch-based encapsulation processes

    Final product types

    • Film-coated tablets
    • Uncoated compressed tablets
    • Gelatin hard capsules
    • Modified release pharmaceutical forms

    2. Contract Development and Manufacturing Organization (CDMO) – Clinical Trial Supplies

    CDMO operations depend on high-purity trazodone for both pilot-scale clinical batch manufacturing and stability study sample preparation. Formulated batches may serve ongoing global clinical trials spanning multiple regions, requiring qualification under investigational drug protocols. Formulation teams align raw material intake and dispensing with clinical protocol specifications and manage blinding requirements for active and comparator arms as appropriate for each study phase.

    Industry compliance standards

    • Good Clinical Practice (GCP, ICH E6)
    • Good Manufacturing Practice for Investigational Medicinal Products (IMPs, EU GMP Annex 13)
    • FDA 21 CFR Part 312 (Investigational New Drug Applications)
    • ISO 9001:2015 Quality Management for sample traceability

    Typical usage ratio

    • Based on clinical protocol, 30mg–200mg unit dose per solid form batch; placebo arm production excludes active ingredient
    • Content uniformity within 95–105% of label claim for clinical compliance

    Downstream process integration

    • Precise API weighing and dispensing under restricted access
    • Use of isolators and nitrogen blanketing during blending for high-value batch integrity
    • Split-batch strategies for investigational blinding

    Final product types

    • Clinical trial oral solid dosage (tablet, capsule)
    • Investigator-blinded comparator samples
    • Lab-scale stability study kits
    • Pilot lots for bioequivalence testing

    3. Veterinary Pharmaceuticals – Companion Animal Sedative Formulations

    Veterinary pharmaceutical manufacturers use trazodone as an active ingredient in oral formulations for companion animal behavioral management and perioperative sedation protocols. Development teams adapt excipient systems to ensure palatability and GI absorption consistent with veterinary pharmacokinetics. Production lines employ dedicated cleaning and cross-contamination control measures to maintain animal-use traceability and batch segregation from human pharmaceutical divisions.

    Industry compliance standards

    • VICH GL9 Good Manufacturing Practice (VICH regions: US FDA, EMA, Japan)
    • US FDA Center for Veterinary Medicine (CVM) cGMP, 21 CFR 210/211 (veterinary-specific variation)
    • Ph. Eur. monographs for veterinary APIs and finished product
    • WHO Guidelines for Veterinary Drug Residues

    Typical usage ratio

    • Dosage strength: 25mg–100mg per unit (chewable/tablet) based on species and weight
    • Final matrix: 5–15% w/w API in blend, adjusted for animal palatability and absorption profile

    Downstream process integration

    • Blend with flavor-masked excipients during pre-compression stage
    • Automated tabletting with in-line hardness and friability control
    • Batch segregation protocols for veterinary and human medical supply lines

    Final product types

    • Chewable veterinary tablets
    • Oral veterinary powders or granules
    • Veterinary oral suspension pre-mixes
    • Small-batch clinical veterinary dosage forms

    4. Active Pharmaceutical Ingredient Supply – Repackaging and Compounding Pharmacies

    Licensed API importers and compounding pharmacies use bulk trazodone to fulfill batch reconstitution orders for hospital and specialty pharmacy chains. Compounding teams require full traceability and chain-of-custody compliance for all incoming lots, with material weighed and prepared under cleanroom ISO 7 or ISO 8 containment. Final compounded solutions or customized oral forms must match individualized prescriptions or off-label protocols authorized by licensed healthcare practitioners.

    Industry compliance standards

    • USP <795> and <797> standards for non-sterile/sterile compounding
    • FDA Drug Quality and Security Act (DQSA) – Section 503A & 503B
    • State pharmacy board GMP regulations
    • DEA regulations for controlled substance handling (if applicable by jurisdiction)

    Typical usage ratio

    • Adjustment per prescription dosages: from 2mg/mL liquid solutions up to 100mg/capsule for solid reconstitution
    • Compounded content within +/- 10% of prescribed strength to ensure clinical safety

    Downstream process integration

    • Material receipt under validated quarantine/release procedures
    • Weighing and solubilization or blending within HEPA-filtered compounding hoods
    • Lot coding and patient-specific dispensing documentation

    Final product types

    • Oral liquid solutions for pediatric or geriatric patients
    • Customized capsules or oral powders
    • Unit dose sachets for hospital administration
    • Veterinary compounded products based on prescription
    Free Quote

    Competitive Trazodone prices that fit your budget—flexible terms and customized quotes for every order.

    For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.

    We will respond to you as soon as possible.

    Tel: +8615371019725

    Email: admin@sinochem-nanjing.com

    Get Free Quote of Sinochem Nanjing Corporation

    Flexible payment, competitive price, premium service - Inquire now!

    Certification & Compliance
    More Introduction

    Trazodone: Product Insight from the Factory Floor

    Understanding Trazodone: A Look Behind the Lab Doors

    Every pallet that leaves our production line carries years of chemical engineering, strict batch-by-batch quality checks, and safety protocols that we never compromise. Trazodone hydrochloride, in tablet or powder form, draws high attention among the pharmaceutical actives we synthesize. Decades on the manufacturing floor give us hands-on experience with its production, and we understand the precise handling and attention it demands. Our team follows every nuance, from weighing raw materials to inspecting the uniform crystalline powder that comes off the dryer, to ensure each kilogram meets the physical description and chemical identity you expect.

    Trazodone’s story inside our plant always starts with careful analysis of the starting amines and other input materials. Every reaction step gets tracked by our chemists in real-time, with repeated sampling to confirm identity and measure trace impurities. Each finished batch must pass stringent in-house analysis for conformity with USP and EP monographs. Over the years, we invested in high-performance liquid chromatography and Fourier-transform infrared spectroscopy to sharpen our batch consistency and minimize cross-contamination. Relying on analytic discipline makes a bigger difference than any glossy specification sheet could show; even the best raw materials can falter without close attention during reaction and drying.

    Precision in Specifications: Beyond Basic Numbers

    Model specification for trazodone from our synthesis line aligns with the standards set in global pharmacopeias. Chemically, it presents as C19H22ClN5O, with trace water contents tightly monitored to prevent physical instability. API purity in our lots lands above 99%, with residual solvents and related substances always tested below approved limits. Water content, by Karl Fischer titration, remains under 1%. We focus on particle fineness and flow properties because these traits affect downstream tableting and blending in customer plants. Tablets reach customers at specified strengths—frequently 50 mg, 100 mg, or 150 mg—ensuring predictable performance in formulation. Each lot gains a unique batch certification from our qualified laboratory, documented with both HPLC chromatograms and impurity profiles.

    Reliable product consistency comes from technical rigor rather than routine. Each batch faces a detailed release protocol with potency, identity, and impurity checks. Rigorous oversight over drying, blending, and tableting prevents formulation setbacks in customer factories. Even process water gets daily quality tests, since even small mineral or organic contamination could compromise the outcome. We do not cut corners—this commitment wins trust with long-time buyers who cannot afford failed formulations or unpredictable stability.

    Usage Patterns: Meeting Industry Demands Off the Shelf

    Trazodone earned its position as an active pharmaceutical ingredient through demonstrated effectiveness in managing mood disorders. Downstream manufacturers count on our purity and sequence integrity to support consistent tablet dissolution and reliable therapeutic action. While clinical settings often focus on human health outcomes, from our vantage point, patient safety means a spotless record for purity, identity, and stability. Our role supports not just patient recovery but the peace of mind of hospitals, compounding pharmacies, and contract manufacturers who stake reputations on every bottle.

    We ship traceable lots to generics producers in high-volume regions and to smaller custom formulators. Some work in high-speed continuous production, where powder flow and compressibility mean smoother shifts and fewer interruptions. Others run pilot batches for reformulated tablets or experimental markets, and they value the documentation on impurity profiles, shelf life, and compressibility that comes with each shipment. Our own team works closely with their technicians, troubleshooting downstream issues if they arise and sharing advice for optimal processing.

    What Makes Trazodone Different: Chemistry Matters

    Put trazodone side by side with other antidepressant APIs and the chemical differences become clear as day. Its structure—a triazolopyridine compound—sets it apart from selective serotonin reuptake inhibitors or tricyclic antidepressants. From a manufacturing perspective, this chemistry demands different solvents, catalysts, and protective atmospheres throughout the cascade of reactions. For example, the heterocycle formation step must hit precise reaction temperatures to avoid by-product formation, unlike more robust tricyclic intermediates. Our staff have learned these conditions through trial and error, tuning process parameters until yields and purity reach commercial scale requirements. Process waste is minimized, an ongoing benefit to plant safety and environmental compliance.

    Beyond the molecule itself, trazodone’s physicochemical properties differ from bulkier tricyclics or sulfur-containing antidepressants. Our manufacturing technicians adjust crystallization protocols, solvent drying rates, and even packaging methods because trazodone is more sensitive to humidity than many similar APIs. Delivered product stability relates directly to our control over these fine points. Our in-house stability chambers run real-time and accelerated aging stock for each lot, with multiple samplings to verify ongoing product robustness not just at release but through to patient use.

    The Human Element: Plant Workers and Scientific Rigor

    For all the talk of automated manufacturing, hands and eyes remain critical at our facility. Old-timers remember when a minor miscue in crystallization could spoil an entire batch, wasting weeks of careful preparation. Even today’s sensors and electronic logs still get paired with ground-level double checks. We employ dedicated plant chemists whose job includes taste tests, olfactory checks, and continuous records of batch color and texture.

    Mistakes can set off ripple effects into downstream health. Quality here is not a slogan, but a daily practice guided by exact science and factory realism. We see every deviation—unexpected hues, off-spec granulation, or odd odor signatures—as an urgent signal for full process review, not something to gloss over. Years of experience tell us that patient safety links directly to the manufacturing pride and responsibility upheld by our frontline team.

    Tracing Safety and Compliance: Lessons Learned Over Years

    Nobody cuts corners on compliance if they plan to stick around in chemical manufacturing. With trazodone, that starts with factory entry: GMP audits, validated cleanrooms, secure raw material storage, and shut-off valves checked by our engineering department every shift. Hazard analysis and critical control points (HACCP) maps outline every risk, backed by live monitoring of temperature and pressure. Chain-of-custody documentation starts from raw material intake and spans every weigh, filtration, drying, and tableting step. These records prove invaluable in trace investigations or audits.

    For customers aiming at European, US, or Japanese regulatory markets, demonstrating full traceability and batch verification never happens by accident. Our team leads annual reviews of cleaning protocols, cross-trains for emergency response, and adopts the latest reporting standards—without waiting for new regulations to force an upgrade. Years of zero major findings in health authority inspections encourage confidence, but it’s day-to-day diligence that keeps our license running and our name respected.

    Navigating Market Needs and Customer Feedback

    Suppliers without up-to-date feedback fall behind in this business. We keep our ears open to technical questions from customer formulators. Common topics include reactivity with specific excipients, long-term stability in global shipping scenarios, or granulation behavior in direct compression lines. In response, we invest in more robust packaging—aluminum barrier liners, vacuum sealing, and desiccant-assisted pouches. Outbound products ship with certificate-of-analysis packets including detailed impurity maps, water content, and particle size analysis. This approach means stability-related recalls remain remote events, not commonplace headaches.

    We also provide supplemental technical support for new entrants and established clients alike. If a new tableting issue crops up at a customer facility, production chemists at our end help dissect the possible source. During partnership reviews, we listen for signs of shifting market preference—like the rise in fixed-dose combination requests—and keep our process flexible for quick response. In the long run, this honest dialogue trims cost for everyone and maintains a steady supply line in volatile global conditions.

    Challenges in the Field: Raw Material Hazards and Solvent Recovery

    Consistent trazodone output relies heavily on raw material quality. Even minor supplier changes upstream risk byproduct increases or yield drops. Bulk amines and precursor intermediates require certified analysis, with our own incoming quality checks backing up vendor documents. If a flag shows up at our gate, the lot is segregated for further testing.

    Solvent management takes up a large part of our environmental compliance efforts. Our process produces streams of organic and aqueous waste. We invested in on-site solvent recovery and distillation. Recycled solvents reach purity targets set by our lab before reintroduction. Continuous monitoring of emissions, and regular cleaning of process equipment, reduce downtime and prevent uncontrolled releases.

    Packing and Storage: Shelf Stability from Our Bench to Yours

    Industry advances mean that many molecules remain stable for years—if handled right. Our packing department adopts nitrogen-flush systems and opaque, high-barrier liners, sealing each drum or tote to keep moisture away. Preprinted batch labels include full trace data back to synthesis and packing. We routinely perform shelf-life extension studies, pulling samples under various conditions and retesting for potency, impurity counts, and water content. This practical focus on downstream storage and shipment helps customers in hot, humid, or variable climates avoid stability failures. Our experience in global markets and feedback from returned samples let us keep improving storage technology.

    Every shipping case meets international codes for hazardous and pharmaceutical goods. Our warehouse maintains strict HVAC monitoring to prevent ambient moisture from creeping into finished stocks. We send regular updates to major buyers if best practices change or new packaging formats show improved outcomes.

    Differences from Other APIs: Processes Tailored to Chemistry

    Some clients ask if producing trazodone compares to well-known SSRIs like fluoxetine or paroxetine. Our answer is practical: every chemical demands optimized conditions. Trazodone’s triazolopyridine base resists hydrolysis better than some SSRIs but suffers more in humid conditions post-synthesis. We tweak crystallization and drying with every lot, using gas-tight dryers and gentle vacuum. Other antidepressants with sulfur groups may need oxidation-resistant materials for stirring and holding; we don’t see this with trazodone, which keeps maintenance and equipment replacement costs lower for us.

    Formulation teams working with multiple antidepressants notice that trazodone flows better as a fine, crystalline powder than waxy or oily bases required for certain others. Fast, predictable dissolution helps downstream operators in tableting rooms avoid sticky batches, uneven blending, or compressibility failures. As manufacturers, our focus stays fixed on the process details that show up in the customer’s final quality assurance report.

    Value-Added through Vertical Integration

    Chemical plants delivering both endpoints—active ingredients and tablets—hold a strong position in today’s market. This integration allows us to test every process change in both synthesis and finished drug form. Vertical workflows shorten performance feedback loops, making it easier to spot outliers in dissolution rate, shelf life, and impurity growth. We learn what works best for downstream blending by tracing how slight shifts in crystallization or drying impact batch tableting efficiency. Pharmaceutical partners count on this transparency, since fewer steps separate their own quality checks from our factory records.

    Several larger generics companies send tech teams to observe our approach and share their own operational data. Over time, these collaborations raise industry standards. We lead joint improvement projects—tracking moisture, blending time, or reactivity data. Our lab can quickly modify a production step to accommodate an evolving market demand, such as modified-release forms or taste-mask coatings. This agility, fine-tuned by field experience, gives us a nimble edge in regulatory audits and customer service.

    Building Trust: Reputation from the Factory to the Pharmacy

    Earning trust in this field takes more than certifications. Hospital buyers and supply chain managers base critical purchasing decisions on batch reliability and recent customer service data. We take pride in years spent delivering without recalls or reportable failures linked to our in-house trazodone. Quality assurance provides certificates for every shipment, and our regulatory team logs near misses and field complaints in a digital system accessible by authorized customers. That’s not just compliance—it’s operational accountability.

    Transparency also means owning up to mistakes. In rare cases where out-of-specification results crop up during internal review, shipments stop, customers receive notice, and corrective action follows before fresh production begins. This culture, built over years, boosts supply chain security for the hundreds of hospitals, clinics, and pharmaceutical compounding labs depending on our lines.

    The Road Ahead: Shifting Demands and Upgrades from the Shop Floor

    Markets keep evolving, and we keep investing in plant upgrades, safety features, and analytic equipment. Regulatory rules drift and sharpen; we track changes, revalidate processes, and adopt new safety limits well before they turn into headlines. Demand for higher-value drug combinations, novel delivery systems, and advanced analytical verification grows each year. Feedback from end-users about packaging, labelling, or document clarity gets immediate review, often leading to real-time improvement. Our teams spot emerging risks—whether in raw material sourcing, unplanned downtime, or regulatory hurdles—and respond with targeted investment.

    Continuous education for both chemical operators and laboratory analysts remains a founding value. We run annual retraining on safe handling, regulatory updates, and analytical technology, using both external consultants and hands-on instruction. These efforts put our staff ahead of field trends and let them intercept warning signs in both plant and regulatory contexts before they escalate.

    Commitment to Customer Outcomes: Beyond the Batch Number

    Nothing in chemical manufacturing compares to the satisfaction of seeing our product on a pharmacy shelf or in a laboratory inventory list. Years of accumulated operational wisdom shape every lot, and each kilogram moving through our lines tells a story our whole plant feels invested in. By focusing on technical rigor, transparent communication, and hands-on collaboration with our customers, we aim to deliver not just compliance, but confidence at every handoff within the supply chain.

    For every new application, regulatory update, or market challenge, we stay ready to support formulation teams, regulatory groups, and downstream quality officers. Feedback from each product cycle translates directly to improved yield, minimized risk, and a smoother journey from synthesis to finished dose.

    Daily hard work, smart engineering, and a little humility keep the doors open and shipments moving. That’s the role we play—from our first beaker of precursor to the last drum out the warehouse door—producing trazodone with pride, purpose, and experience shaped by real-world demand.